Why Democracy Needs Data—and What Happens When It Vanishes

In the first few months of Donald Trump’s return to the presidency, one thing has become crystal clear: The war on gender and racial equity is being waged in a new arena—on the battleground of data.

This fight isn’t waged with tweets or soundbites. It’s carried out through budget cuts, shuttered research programs and disappearing federal surveys. It’s a quiet but devastating assault on the tools we rely on to tell the truth—and to hold those in power accountable. And the message is chilling: If we can’t measure inequality, maybe we can pretend it doesn’t exist.

When race is stripped from maternal health reports, we overlook the crisis facing Black mothers. When LGBTQ+ identity is erased from youth surveys, we lose critical insight into mental health and safety. When disability status is omitted from labor market data, inequities in access and pay go unaddressed.

We need a renewed federal commitment to the research infrastructure that allows us to see and solve inequality—not ignore it.

Federal Court Considers Removing Medically Unnecessary FDA Restrictions on Abortion Pills

The FDA maintains burdensome, medically unnecessary restrictions on mifepristone, which is used in combination with another medication—misoprostol—for early pregnancy termination. This combination of medications is safer than Viagra and Tylenol and is now used in approximately two-thirds of all abortions in the United States.

Over the last decade, the FDA has removed some of the restrictions on mifepristone, including a requirement that the medication be dispensed in person by doctors, but the agency still requires prescribers and pharmacies to register with the drug maker and requires patients to sign a counseling form with redundant, inaccurate and confusing information, all of which has decreased access to the medication.

To remove these requirements, the Center for Reproductive Rights filed a lawsuit in May 2023, Whole Woman’s Health Alliance v. U.S. Food and Drug Administration, asking a federal district court in Charlottesville, Va., to order the FDA to lift these restrictions on mifepristone.

On Monday, May 19, 2025, the court heard oral arguments on cross motions for summary judgment in the case. “The Trump administration has made it clear that they do not care about science, or our health and safety,” said CRR on social media. “They only care about taking away our rights. But we refuse to let that happen. We’re ALL IN on this fight.”

Republican Efforts to Defund Planned Parenthood Would Increase Budget Deficit $300 Million

The House Rules Committee is set to meet at 1 a.m. ET on May 21 to discuss Medicaid funding cuts that would essentially defund Planned Parenthood. The nonpartisan Congressional Budget Office estimates that blocking patients from using their Medicaid insurance plan to obtain sexual and reproductive healthcare at Planned Parenthood clinics would increase the deficit by $300 million.

“The fact of the matter is, if Republicans get their way—if they succeed in shutting the doors of Planned Parenthood clinics across the country—millions of women will have nowhere else to turn,” said Sen. Patty Murray (D-Wash.). “After all, two-thirds of Planned Parenthood health centers are in rural and medically underserved areas—places where there’s already a shortage of clinics and healthcare professionals. And for a lot of these patients, Planned Parenthood is literally the only provider in reach and in budget. They literally can’t afford to lose this care.”

Adriana Smith and the Legal Horror of Reproductive Servitude in the U.S.

Three months ago, 30-year-old Adriana Smith was declared brain-dead. But a hospital in Georgia is keeping her “alive” on life support because of the state’s strict abortion ban.

“In what universe does a hospital in Georgia … believe that they can take ownership of Adriana Smith’s body?” asked Michele Goodwin on a recent emergency episode of On the Issues: Fifteen Minutes of Feminism. “According to the hospital, she is now an incubator. … This is not science fiction, though I wish that it were.”

“I think every woman should have the right to make their own decision,” Smith’s mother, April Newkirk, said. “And if not, then their partner or their parents.”

Worldwide, Many Women Relied on the U.S. for Financial Support. This Afghan Woman Dares to Speak Out.

I’ve been writing for decades about America’s on-again-off-again support for the reproductive healthcare of women around the world, focusing on the Republican presidents who have slashed funding and jeopardized women’s lives.

When I spoke by phone to Seema Ghani in February, there was something more. Unlike many women I had reached out to this year in countries that have relied on the United States for financial support, Ghani was not afraid to speak to me—even though her homeland, Afghanistan, is the world’s most oppressive for women.

FDA Review of Abortion Pill Signals First Step Toward Nationwide Ban

In a stunning move that could mark the first step toward a nationwide ban on abortion pills, Health and Human Services Secretary Robert F. Kennedy Jr. has ordered the FDA to reevaluate its decades-old approval of mifepristone—a medication used safely by over 7.5 million Americans over the last quarter-century for abortion and treatment of miscarriages.

The directive, based on a single junk-science report from an antiabortion group, signals a dangerous shift: the politicization of FDA policy and a coordinated push to strip access to medication abortion across the country.

Our Abortion Stories: ‘I Have the Privilege to Live in a State Where I Am Safe’

“If she could have put off the baby for two more years, she could have saved up a nest egg and created her family the way she wanted. Instead, she was trapped with a baby too soon.”

Abortions are sought by a wide range of people for many different reasons. There is no single story. Telling stories of then and now shows how critical abortion has been and continues to be for women and girls. (Share your abortion story by emailing myabortionstory@msmagazine.com.)

“Seven more days. To find out what is happening inside my body. What is poisoning my body. Starving my body. Starving my life of joy and laughter.”

Defunding and Refunding the Women’s Health Initiative: Why States Must Focus on Menopausal Women’s Health

The ongoing decimation of the federal funding landscape brings some good(ish) news for women: the role of state legislatures in stepping up to help improve and advance the health of menopausal women.

Thus far, 13 states—a record one in four—have introduced more than 20 bills focused on menopause care, proposing changes that could permanently reshape insurance coverage and educational and health care resources. Public officials in Michigan, Illinois and West Virginia announced support for menopause reforms. Michigan Gov. Gretchen Whitmer recently hosted a roundtable for leaders and a statewide listening tour. The latest slate of bills—introduced in red and blue states alike—would bolster workplace supports and dedicate resources to public education. The bills are being proposed at such a fast clip that menopause was named on a “Ones To Watch: Legislation Landscape for 2025” list.